These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6984510)

  • 1. Normal differentiation and genetic changes in cancer cells.
    Sachs L
    Prog Clin Biol Res; 1982; 103 Pt B():259-66. PubMed ID: 6984510
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of normal differentiation and restoration of the normal phenotype in leukemia.
    Sachs L
    Natl Cancer Inst Monogr; 1982; 60():221-7. PubMed ID: 6981773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulators of normal development and tumor suppression.
    Sachs L
    Int J Dev Biol; 1993 Mar; 37(1):51-9. PubMed ID: 8507571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of membrane changes, differentiation, and malignancy in carcinogenesis.
    Sachs L
    Harvey Lect; 1974; 68():1-35. PubMed ID: 4375672
    [No Abstract]   [Full Text] [Related]  

  • 6. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.
    Krivtsov AV; Twomey D; Feng Z; Stubbs MC; Wang Y; Faber J; Levine JE; Wang J; Hahn WC; Gilliland DG; Golub TR; Armstrong SA
    Nature; 2006 Aug; 442(7104):818-22. PubMed ID: 16862118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLL-ENL causes a reversible and myc-dependent block of myelomonocytic cell differentiation.
    Schreiner S; Birke M; García-Cuéllar MP; Zilles O; Greil J; Slany RK
    Cancer Res; 2001 Sep; 61(17):6480-6. PubMed ID: 11522644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cultures in acute leukemia of childhood.
    Ragab AH; Kennedy MS; Findley HW; Lui VK
    Am J Pediatr Hematol Oncol; 1981; 3(4):419-24. PubMed ID: 7036782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and therapeutic implications of cell cultures for human leukemias.
    Sachs L
    Recent Results Cancer Res; 1979; 69():15-23. PubMed ID: 314137
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent.
    Song LP; Zhang J; Wu SF; Huang Y; Zhao Q; Cao JP; Wu YL; Wang LS; Chen GQ
    Oncogene; 2008 Jan; 27(4):519-27. PubMed ID: 17637739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective up-regulation of phospholipase C-beta2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors.
    Bertagnolo V; Marchisio M; Pierpaoli S; Colamussi ML; Brugnoli F; Visani G; Zauli G; Capitani S
    J Leukoc Biol; 2002 Jun; 71(6):957-65. PubMed ID: 12050180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant dendritic cell differentiation initiated by the Mll-Een fusion gene does not require leukemic transformation.
    Sun Q; Kong CT; Huang FP; Chan LC
    J Leukoc Biol; 2008 Jan; 83(1):173-80. PubMed ID: 17895399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic versus acute myelogenous leukemia: a question of self-renewal.
    Jamieson CH; Weissman IL; Passegué E
    Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factors in myeloid development: balancing differentiation with transformation.
    Rosenbauer F; Tenen DG
    Nat Rev Immunol; 2007 Feb; 7(2):105-17. PubMed ID: 17259967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Membrane dynamics, cell recognition, and malignancy.
    Sachs L
    J Biochem; 1976 Apr; 79(4):26P. PubMed ID: 931960
    [No Abstract]   [Full Text] [Related]  

  • 17. Concepts of human leukemic development.
    Warner JK; Wang JC; Hope KJ; Jin L; Dick JE
    Oncogene; 2004 Sep; 23(43):7164-77. PubMed ID: 15378077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine control of developmental programs in normal hematopoiesis and leukemia.
    Lotem J; Sachs L
    Oncogene; 2002 May; 21(21):3284-94. PubMed ID: 12032770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo.
    Just U; Spooncer E; Löhler J; Stocking C; Ostertag W; Dexter TM
    Exp Hematol; 1994 Aug; 22(9):933-40. PubMed ID: 8062891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.